Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy

Background: Invasive and non-invasive pneumococcal diseases are significant health and economic burdens, especially in children and the elderly. Italy included the 7-valent (PCV7) and 13-valent pneumococcal conjugate vaccine (PCV13) in the National Immunization Program in 2007 and 2010, respectively...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pathogens
Auteurs principaux: Ansaldi, Filippo, Pugh, Sarah, Amicizia, Daniela, Di Virgilio, Roberto, Trucchi, Cecilia, Orsi, Andrea, Zollo, Alessandro, Icardi, Giancarlo
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7168640/
https://ncbi.nlm.nih.gov/pubmed/31979079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pathogens9020076
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires